Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration
about
Transient opening of the perineurial barrier for analgesic drug deliveryUridine 5'-triphosphate promotes in vitro Schwannoma cell migration through matrix metalloproteinase-2 activationCytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve.MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat.TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve.Delayed Gelatinase Inhibition Induces Reticulon 4 Receptor Expression in the Peri-Infarct Cortex.Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane.Biologically inspired approaches to drug delivery for nerve regeneration.MMP-9 controls Schwann cell proliferation and phenotypic remodeling via IGF-1 and ErbB receptor-mediated activation of MEK/ERK pathway.Downstream effector molecules in successful peripheral nerve regeneration.Matrix metalloproteinase 3 deletion preserves denervated motor endplates after traumatic nerve injury.Transcriptional mechanisms underlying sensitization of peripheral sensory neurons by granulocyte-/granulocyte-macrophage colony stimulating factors.Matrix metalloproteinase-2 is downregulated in sciatic nerve by streptozotocin induced diabetes and/or treatment with minocycline: Implications for nerve regeneration.Characterization of matrix metalloproteinases in denervated muscle.
P2860
Q28568470-2702C944-EA9A-4983-B7F8-8395880F0995Q33721426-9AC6102C-9980-4A8C-8C98-AF64F99E6EDFQ33834853-09F9CF45-F46E-4710-BC9C-379F3FE7B866Q33847555-6E08863C-6564-4FF3-A740-C353C582697EQ35606343-241802F8-7C71-476E-A659-8ADA59B3A3E3Q35946406-AA2AC12D-D2C5-4455-A3D1-E9ECDAEDBF05Q35987510-9BF5D708-A4FB-4938-A32E-4284E96C9B4DQ36627231-3C50091F-30FC-4E68-AF7E-B414A5035479Q37268755-86DE4B03-5932-4FE1-8C0F-BAA58A2C1CADQ38009650-AEC8DE7B-4277-417F-BDDD-6EF6A5D6DA64Q39217878-4732C2E0-57BD-4D99-B34A-6147889D931BQ42844654-7B8EDBDE-3FFF-41D1-82E7-C6E7A9ECE932Q42947312-95703A3C-3591-45E4-9C0F-8955792B5C3DQ54644610-373E88D2-33B4-41B2-B242-02DD65093920
P2860
Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration
description
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Jahr 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/01/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/01/01)
@nl
наукова стаття, опублікована в січні 2004
@uk
مقالة علمية (نشرت عام 2004)
@ar
name
Characterisation of matrix met ...... peripheral nerve regeneration
@ast
Characterisation of matrix met ...... peripheral nerve regeneration
@en
Characterisation of matrix met ...... peripheral nerve regeneration
@nl
type
label
Characterisation of matrix met ...... peripheral nerve regeneration
@ast
Characterisation of matrix met ...... peripheral nerve regeneration
@en
Characterisation of matrix met ...... peripheral nerve regeneration
@nl
prefLabel
Characterisation of matrix met ...... peripheral nerve regeneration
@ast
Characterisation of matrix met ...... peripheral nerve regeneration
@en
Characterisation of matrix met ...... peripheral nerve regeneration
@nl
P2093
P1433
P1476
Characterisation of matrix met ...... peripheral nerve regeneration
@en
P2093
A. J. Gearing
G. M. Wells
K. J. Smith
K. M. Miller
M. Demestre
N. A. Gregson
R. a. C. Hughes
P304
P356
10.1016/J.NEUROSCIENCE.2003.12.037
P407
P577
2004-01-01T00:00:00Z